Actinogen Medical Limited (AU:ACW) has released an update.
Actinogen Medical Limited has announced a Share Purchase Plan (SPP) offering up to 100 million new shares at $0.03 each to raise about $3 million, with additional options available. The offer, managed by Bell Potter and Moelis Australia, is not underwritten and aims to fund the company’s growth. Investors are advised to consider the associated risks and consult professional advisers as the company’s past performance does not guarantee future results.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
